tiprankstipranks
Predictive Oncology Inc (POAI)
NASDAQ:POAI

Predictive Oncology Stock Analysis & Ratings

POAI Stock Chart & Stats

Day’s Range$0.35 - $0.3885
52-Week Range$0.36 - $1.64
Previous Close$0.38
Volume916.37K
Average Volume (3M)503.75K
Market Cap$5.58M
P/E Ratio-1.1
Beta0.54
Next EarningsAug 17, 2022
EPS ForecastN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart ScoreN/A
EPS (TTM)-0.36


Predictive Oncology News

Currently, no data available
Please return soon. This page is being updated.

---

Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

POAI FAQ

What was Predictive Oncology’s price range in the past 12 months?
Predictive Oncology lowest stock price was $0.36 and its highest was $1.64 in the past 12 months.
    What is Predictive Oncology’s market cap?
    Predictive Oncology’s market cap is $5.58M.
      What is Predictive Oncology’s price target?
      Currently, no data Available
      What do analysts say about Predictive Oncology?
      Not enough analysts have published a price target to provide an average price target.
      When is Predictive Oncology’s upcoming earnings report date?
      Predictive Oncology’s upcoming earnings report date is Aug 17, 2022 which is in 91 days.
        How were Predictive Oncology’s earnings last quarter?
        Currently, no data Available
        Is Predictive Oncology overvalued?
        According to Wall Street analysts Predictive Oncology’s price is currently Overvalued.
          Does Predictive Oncology pay dividends?
          Predictive Oncology does not currently pay dividends.
          What is Predictive Oncology’s EPS estimate?
          Predictive Oncology’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Predictive Oncology have?
          Predictive Oncology has 15,420,000 shares outstanding.
            What happened to Predictive Oncology’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Predictive Oncology?
            Currently, no hedge funds are holding shares in POAI

            ---

            Predictive Oncology Stock Analysis

            Smart Score
            N/A
            Not Ranked
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10
            Price Target
            No data currently available
            This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
            Learn more about TipRanks Smart Score

            Company Description

            Predictive Oncology Inc

            Predictive Oncology, Inc. engages in the manufacture and distribution of healthcare products, and provision of related services. The company offers STREAMWAY System, which is an automated system for the collection and disposal of infectious fluids from surgical and other medical procedures. It operates through the Medical Device and Consumable Products segments. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.

            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Avanos Medical

            Popular Stocks

            ---
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis